P

Inventor

FU WENLANG

US11 patents
⚠️ This page may combine multiple inventors who share the name “FU WENLANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK SHARP & DOHME LLC

3 patents
US12454525B2Oct 28, 2025

IL4I1 inhibitors and methods of use

MERCK SHARP & DOHME LLC0 citations58
US12492187B2Dec 9, 2025

Factor XI activation inhibitors

MERCK SHARP & DOHME LLC0 citations49
US12304899B2May 20, 2025

Factor XI activation inhibitors

MERCK SHARP & DOHME LLC0 citations49

BAYER PHARMACEUTICALS CORP

2 patents
US7563791B2Jul 21, 2009

Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

BAYER PHARMACEUTICALS CORP14 citations82
US7582645B2Sep 1, 2009

Pyrimidine derivatives for treatment of hyperproliferative disorders

BAYER PHARMACEUTICALS CORP4 citations61

BUTORA GABOR

1 patent
US8877439B2Nov 4, 2014

Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications

BUTORA GABOR22 citations88

MERCK SHARP & DOHME

1 patent
US10450335B2Oct 22, 2019

Antiviral oxime phosphoramide compounds

MERCK SHARP & DOHME3 citations72

SIRNA THERAPEUTICS INC

1 patent
US9512426B2Dec 6, 2016

Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications

SIRNA THERAPEUTICS INC2 citations61

BAYER HEALTHCARE LLC

1 patent
US7678804B2Mar 16, 2010

Pyrimidine derivatives for treatment of hyperproliferative disorders

BAYER HEALTHCARE LLC4 citations61

DIXON JULIE A

1 patent
US8338595B2Dec 25, 2012

Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis

DIXON JULIE A0 citations48

KLAR JÜRGEN

1 patent
US9040691B2May 26, 2015

Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors

KLAR JÜRGEN1 citations43